Jump to main content
Jump to site search

Issue 9, 2018
Previous Article Next Article

Teratogen screening with human pluripotent stem cells

Author affiliations


Birth defects are a common occurrence in the United States and worldwide. Currently, evaluation of potential developmental toxicants (i.e., teratogens) relies heavily on animal-based models which do not always adequately mimic human development. In order to address this, researchers are developing in vitro human-based models which utilize human pluripotent stem cells (hPSCs) to assess the teratogenic potential of chemical substances. The field of human developmental toxicity assays includes a variety of platforms including monolayer, micropattern, embryoid body, and 3D organoid cultures. In this review, we will overview the field of human teratogenic assays, detail the most recent advances, and discuss current limitations and future perspectives.

Graphical abstract: Teratogen screening with human pluripotent stem cells

Back to tab navigation

Article information

08 May 2018
30 Jul 2018
First published
31 Jul 2018

Integr. Biol., 2018,10, 491-501
Article type
Review Article
Author version available

Search articles by author